ADIPOQ and Hyperglycemia: As SARS-CoV-2 induces adipose tissue dysfunction by binding to ACE2 receptor [8], the reduction of adiponectin and adiponectin/leptin ratio is associated with the increase in type I interferon signaling pathway and activation of the innate immune response, which leads to insulin resistance and, consequently, hyperglycemia [28].